"Let\'s ShapeLG\'s Future with the DNA of Challenge and Change We\'ve had Since Day 1" HighlightingLG\'s Spirit – the DNA of challenge and change since Day 1
The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS,the premier global congress in aesthetic medicine. The data will be highlighted in both the 2025 fo
Advances the development and deployment of flagship products Eureka Controller and Eureka 3D Camera Scales operations in Singapore and Japan,and enables full entry in the US market
ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis
SHENZHEN,China,Dec. 12,2024-- Saint-Gobain Group,a global leader in lightweight and sustainable construction solutions,reinvested in the Luohu district of Shenzhen this year.
CHONGQING,China,Dec. 12,2024-- Recently,Porton Pharma Solutions Ltd. ("Porton") announced a strategic partnership with Aojin Life Sciences (Yixing) Co.,Ltd. ("Aojin Life Sciences")
